Almirall ( (ES:ALM) ) has issued an announcement.
Almirall’s Annual Corporate Governance Report reveals that as of December 31, 2024, the company had a share capital of €25,616,246.16 with 213,468,718 voting rights, indicating no special voting rights for loyalty or different share classes. This report highlights Almirall’s transparent corporate structure and governance practices, which could reassure investors and stakeholders of the company’s stable management and commitment to equitable shareholder engagement.
More about Almirall
Almirall, S.A. operates in the pharmaceutical industry, focusing on developing and distributing medicines primarily in the dermatology sector. The company is known for its commitment to advancing healthcare solutions and operates with a market focus on improving patient outcomes.
YTD Price Performance: 13.30%
Average Trading Volume: 3,485
Technical Sentiment Consensus Rating: Sell
Current Market Cap: €1.94B
For a thorough assessment of ALM stock, go to TipRanks’ Stock Analysis page.